CD44-Deficient mice exhibit enhanced hepatitis after concanavalin A injection: Evidence for involvement of CD44 in activation-induced cell death

Journal of Immunology

Volumn 166, Issue 10, 2001, Pages 5889-5897

  Chen, Dawei ^a   McKallip, Robert J ^b   Zeytun, Ahmet ^b   Do, Yoonkyung ^b   Lombard, Catherine ^b   Robertson, John L ^a   Mak, Tak W ^c   Nagarkatti, Prakash S ^b   Nagarkatti, Mitzi ^b  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CONCANAVALIN A; CYTOKINE; FAS ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEPATITIS; KNOCKOUT MOUSE; LIVER CELL; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0035873417     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.10.5889     Document Type: Article

References (32)

1. Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90:196.
2. Lohse, A. W., H. P. Dienes, and K. H. Meyer zum Buschenfelde. 1998. Suppression of murine experimental autoimmune hepatitis by T cell vaccination or immunosuppression. Hepatology 27:1536.
3. Decker, K., and D. Keppler. 1974. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev. Physiol. Biochem. Pharmacol. 71:77.
4. Kaneko, Y., M. Harada, T. Kawano, M. Yamashita, Y. Shibata, F. Gejyo, T. Nakayama, and M. Taniguchi. 2000. Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191:105.
5. Okamoto, T., Y. Nakano, W. Asakura, T. Kobayashi, N. Tsuzuike, and K. Hara. 1998. Expression of cytokine mRNA in extrahepatic organs in a mouse concanavalin A-hepatitis model. Jpn. J. Pharmacol. 77:219.
6. Cao, Q., R. Batey, G. Pang, A. Russell, and R. Clancy. 1998. IL-6, IFN-γ and TNF-α production by liver-associated T cells and acute liver injury in rats administered concanavalin A. Immunol. Cell Biol. 76:542.
7. Haynes, B. F., M. J. Telen, L. P. Hale, and S. M. Denning. 1989. CD44: a molecule involved in leukocyte adherence and T-cell activation. Immunol. Today 10:423.
8. Lesley, J., R. Hyman, and P. W. Kincade. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271.
9. Flanagan, B. F., R. Dalchau, A. K. Allen, A. S. Daar, and J. W. Fabre. 1989. Chemical composition and tissue distribution of the human CDw44 glycoprotein. Immunol. 67:167.
10. Miyake, K., K. L. Medina, S. I. Hayashi, S. Ono, T. Hamaoka, and P. W. Kincade. 1990. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. 171:477.
11. Seth, A., L. Gote, M. Nagarkatti, and P. S. Nagarkatti, 1991. T cell receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14. Proc. Natl. Acad. Sci. USA 88:7877.
12. Hammond, D. M., P. S. Nagarkatti, L. R. Gote, A. Seth, M.R. Hassuneh, and M. Nagarkatti. 1993. Double-negative T cells from MRL-lprllpr mice mediate cytolytic activity when triggered through adhesion molecules and constitutively express perforin gene. J. Exp. Med. 178:2225.
13. Rafi, A., M. Nagarkatti, and P. Nagarkatti. 1997. Hyaluronate-CD44 interactions can induce murine B-cell activation. Blood 89:2901.
14. Huet, S., H. Groux, B. Caillou, H. Valentin, M. Prieur, and A. Bernard. 1989. CD44 contributes to T cell activation. J. Immunol. 143:798.
15. Rothman, B., M. Blue, K. Kelley, D. Wunderlich, D. Mierz, and T. Aune. 1991. Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44. J. Immunol. 147:2493.
16. Rafi-Janajreh, A. Q., D. Chen, R. Schmits, T. W. Mak, R. L. Grayson, D. P. Sponenberg, M. Nagarkatti, and P. S. Nagarkatti. 1999. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. J. Immunol. 163:1619.
17. Schmits, R., J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al. 1997. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90:2217.
18. Goossens, P. L., H. Jouin, G. Marchal and G. Milon. 1990. Isolation and flow cytometric analysis of the free lymphomyeloid cells present in murine liver. J. Immunol. Methods 132:137.
19. Watanabe, H., K. Ohtsuka, M. Kinura, Y. Ikarashi, K. Ohmori, A. Kusumi, T. Ohteki, S. Seki, and T. Abo. 1992. Details of an isolation method for hepatic lymphocytes in mice. J. Immunol. Methods 146:145.
20. Kamath, A. B., H. Xu, P. S. Nagarkatti, and M. Nagarkatti. 1997. Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo. Toxicol. Appl. Pharmacol. 142:367.
21. Vermes, I., C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger. 1995. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J. Immunol. Methods 184:39.
22. Radvanyi, L. G., K. Raju, D. Spaner, G. B. Mills, and R. G. Miller. 1998. Interleukin-2 reverses the defect in activation T cells for autoimmune lpr mice. Cell Immunol. 183:1.
23. + organs. Blood 95:2111.
24. Okamoto, T., O. Maeda, N. Tsuzuike, and K. Hara. 1998. Effect of gadolinium chloride treatment on concanavalin A-induced cytokine mRNA expression in mouse liver. Jpn. J. Pharmacol. 78:101.
25. Gantner, F., M. Leist, A. W. Lohse, P. G. Germann, and G. Tiegs. 1995. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21:190.
26. Misuhara, H., E. O'Neill, N. Seki, N., T. Ogawa, C. Kusunoke, K. Otsuke, S. Satoh, M. Niwa, H. Senoh, and H. Fujiwara. 1998. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179:1529.
27. Tagawa, Y., K. Sekikawa, and Y. Iwakura. 1997. Suppression of concanavalin A-induced hepatitis in IFN-γ / mice, but not in TNF-α / mice: role for IFN-γ in activating apoptosis of hepatocytes J. Immunol. 159:1418.
28. Watanahe, Y., M. Morita, and T. Akaike. 1996. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 24:702.
29. Russell, J. H. 1995. Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol. 7:382.
30. Kabelitz, D., T. Pohl, and K. Pechhold. 1993. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol. Today 14:338.
31. + T cells for concanavalin A-induced hepatic injury in mice. J. Immunol. 159:1537.
32. Nicoletti, F., B. Beltrami, H. Raschi, R. Di Marco, G. Magro, S. Grasso, K. Bendtzen, G. Fiorelli, and P. L. Meroni. 1997. Protection from concanavalin A (Con A)-induced T cell-dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate. Clin. Exp. Immunol. 110:479.